Innovation of the process of production of veterinary vaccines against leptospirosis and disease (Q9935)

From EU Knowledge Graph
Revision as of 14:56, 22 October 2020 by DG Regio (talk | contribs) (‎Removed claim: summary (P836): The purpose of the project is to innovate the process of producing and cultivating vaccines against leptospirosis and borreliosis based on the multiplication of spirochet fermentation culture in an industrial bioreactor. The process of innovation will be realised through the introduction of new technology for producing antigens. Innovation covers a wide range of products (e.g.: Biocan L, Biocan Novel L4, B BioBos L, BioBos L6, Biofl B, Biocan...)
Jump to navigation Jump to search
Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Innovation of the process of production of veterinary vaccines against leptospirosis and disease
Project in Czech Republic financed by DG Regio

    Statements

    country
    Czechia
    0 references
    EU contribution
    7,500,000.0 Czech koruna
    0 references
    300,000.0 Euro
    exchange rate to Euro
    0.04 Euro
    point in time
    10 January 2020
    0 references
    budget
    30,000,000.0 Czech koruna
    0 references
    1,200,000.0 Euro
    exchange rate to Euro
    0.04 Euro
    point in time
    10 January 2020
    0 references
    co-financing rate
    25 percent
    0 references
    start time
    19 November 2015
    0 references
    end time
    23 August 2018
    0 references
    expected end time
    1 October 2018
    0 references
    beneficiary name (string)
    Bioveta, a.s.
    0 references
    beneficiary
    Bioveta
    0 references
    coordinate location

    49°18'9.65"N, 17°4'54.52"E
    0 references

    49°17'53.88"N, 17°6'21.31"E
    0 references
    postal code
    68323
    0 references
    summary
    Předmětem projektu je inovace procesu výroby a kultivace vakcín proti leptospiróze a borelióze založená na pomnožení spirochet fermentační kultivací v průmyslovém bioreaktoru. Inovace procesu bude realizována formou zavedení nové technologie výroby antigenů. Inovace se týká celé řady přípravků (např. Biocan L, Biocan Novel L4, B BioBos L, BioBos L6, Biofel B, Biocan B, Borrelym). V rámci projektu bude pořízena technologie pro nový způsob výroby, a to bioreaktory, formulační kotel a ultrafiltr. a. (Czech)
    0 references

    Identifiers

    Czech Kohesio ID
    CZ.01.1.02/0.0/0.0/15_014/0004382
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q9935&oldid=6594755"